PMEF
ELV icon

Point72 Middle East FZE’s Elevance Health ELV Stock Holding History

Point72 Middle East FZE’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,700
Closed -$1.27M – 433
2023
Q4 		$1.27M Sell
2,700
-4,600
-63% -$2.13M 0.04% 526
2023
Q3 		$3.18M Buy
7,300
+5,300
+265% +$2.4M 0.1% 240
2023
Q2 		$889K Buy
2,000
+1,100
+122% +$507K 0.02% 624
2023
Q1 		$414K Sell
900
-1,500
-63% -$714K 0.01% 740
2022
Q4 		$1.23M Buy
+2,400
New +$1.22M 0.05% 450

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Middle East FZE's ELV Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 32,419 shares — an estimated $15.3M sold.

Point72 Middle East FZE first reported a position in ELV in Q1 2023 and held it in 4 quarters. The position peaked at $24.3M in Q2 2023. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 32,419 Elevance Health shares in Q1 2024, an estimated $15.3M.
  • Point72 Middle East FZE first reported a position in Elevance Health in Q1 2023 and held it in 4 quarters.
  • Point72 Middle East FZE's Elevance Health position peaked at $24.3M in Q2 2023.
  • 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.